Antiretroviral Therapy Use, Medication Adherence, and Viral Suppression Among PLWHA with Panic Symptoms

AIDS Behav. 2015 Nov;19(11):2049-56. doi: 10.1007/s10461-015-1064-4.

Abstract

Panic symptoms are prevalent among PLWHAs, yet few studies have examined their relationship with HIV outcomes. Using data from an observational cohort study in Baltimore, MD, we examined the association between panic symptoms and antiretroviral therapy (ART) use, medication adherence, and viral suppression. Data were analyzed using generalized estimating equations and adjusted for age, sex, race/ethnicity, cocaine and/or heroin use, clinic enrollment time, alcohol use, and depressive symptoms. Between June 2010 and September 2012, 1195 individuals participated in 2080 audio computer assisted interviews; 9.9 % (n = 118) of individuals endorsed current panic symptoms. In multivariate analysis, panic symptoms were associated with decreased ART use (IRR 0.94; p = 0.05). Panic symptoms were neither associated with medication adherence nor viral suppression. These findings were independent of depressive symptoms and substance use. Panic symptoms are under-recognized in primary care settings and present an important barrier to ART use. Further studies investigating the reasons for this association are needed.

Keywords: Antiretroviral therapy use; Medication adherence; Panic symptoms; Psychiatric disorder; Viral suppression.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Aged
  • Alcohol Drinking / psychology
  • Anti-HIV Agents / therapeutic use
  • Antiretroviral Therapy, Highly Active*
  • Baltimore
  • CD4 Lymphocyte Count
  • Depression / diagnosis
  • Depression / psychology
  • Female
  • HIV Infections / drug therapy*
  • HIV Infections / psychology*
  • HIV Infections / virology
  • Humans
  • Male
  • Medication Adherence*
  • Middle Aged
  • Panic*
  • Prospective Studies
  • Substance-Related Disorders / complications
  • Treatment Outcome
  • Viral Load / drug effects*
  • Young Adult

Substances

  • Anti-HIV Agents